Large study compares EES and SES outcomes
Published
02 July 2012
| Article by Circulation: Cardiovascular Interventions 2012
Large study compares EES and SES outcomes
First generation drug-eluting stents (DES) releasing sirolimus or paclitaxel have been shown to reduce the risk of restenosis and repeat revascularization after percutaneous coronary intervention (PCI), as compared with bare-metal stents. However, these DES also have been associated with a risk of late...
To read the full article, please register for GetInsideHealth below.
Register for GetInsideHealth
GetInsideHealth is free and registration is easy. You'll have exclusive access to a huge range of industry-specific features and news reports from some of the most respected commentators on health and well-being, with an emphasis on the latest developments and innovations in cardiology, oncology, radiology, and OBGYN.
Please fill in the form below to register.
Already Registered?
Please login using
form at top of page
Fields with an asterisk (*) are mandatory
About you
Login information
Newsletter
Additional information